{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:56:27Z","timestamp":1790139387299,"version":"4.0.1"},"publisher-location":"Cham","reference-count":75,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319896885","type":"print"},{"value":"9783319896892","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-89689-2_10","type":"book-chapter","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T12:01:22Z","timestamp":1529323282000},"page":"265-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Senataxin, A Novel Helicase at the Interface of RNA Transcriptome Regulation and Neurobiology: From Normal Function to Pathological Roles in Motor Neuron Disease and Cerebellar Degeneration"],"prefix":"10.1007","author":[{"given":"Craig L.","family":"Bennett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert R.","family":"La Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/brain\/awh080","volume":"127","author":"I Ber Le","year":"2004","unstructured":"Le Ber I, et al. Frequency and phenotypic spectrum of ataxia with oculomotor apraxia 2: a clinical and genetic study in 18 patients. Brain. 2004;127:759\u201367.","journal-title":"Brain"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/brain\/122.8.1539","volume":"122","author":"BA Rabin","year":"1999","unstructured":"Rabin BA, et al. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain. 1999;122:1539\u201350.","journal-title":"Brain"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ana.24306","volume":"77","author":"J Cady","year":"2015","unstructured":"Cady J, et al. Amyotrophic lateral sclerosis onset is influenced by the burden of rare variants in known amyotrophic lateral sclerosis genes. Ann Neurol. 2015;77:100\u201313.","journal-title":"Ann Neurol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1086\/421054","volume":"74","author":"YZ Chen","year":"2004","unstructured":"Chen YZ, et al. DNA\/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004;74:1128\u201335.","journal-title":"Am J Hum Genet"},{"key":"10_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ng1303","volume":"36","author":"MC Moreira","year":"2004","unstructured":"Moreira MC, et al. Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nat Genet. 2004;36:225\u20137.","journal-title":"Nat Genet"},{"key":"10_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.1221592","volume":"337","author":"K Padmanabhan","year":"2012","unstructured":"Padmanabhan K, Robles MS, Westerling T, Weitz CJ. Feedback regulation of transcriptional termination by the mammalian circadian clock PERIOD complex. Science. 2012;337:599\u2013602.","journal-title":"Science"},{"key":"10_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1128\/MCB.01195-12","volume":"33","author":"O Yuce","year":"2013","unstructured":"Yuce O, West SC. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol Cell Biol. 2013;33:406\u201317.","journal-title":"Mol Cell Biol"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1093\/nar\/gkh561","volume":"32","author":"D Ursic","year":"2004","unstructured":"Ursic D, Chinchilla K, Finkel JS, Culbertson MR. Multiple protein\/protein and protein\/RNA interactions suggest roles for yeast DNA\/RNA helicase Sen1p in transcription, transcription-coupled DNA repair and RNA processing. Nucleic Acids Res. 2004;32:2441\u201352.","journal-title":"Nucleic Acids Res"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1203\/00006450-199902000-00001","volume":"45","author":"JR Lupski","year":"1999","unstructured":"Lupski JR. Charcot-Marie-tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity. Pediatr Res. 1999;45:159\u201365.","journal-title":"Pediatr Res"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<362::AID-HUMU10>3.0.CO;2-0","volume":"8","author":"LE Warner","year":"1996","unstructured":"Warner LE, Roa BB, Lupski JR. Absence of PMP22 coding region mutations in CMT1A duplication patients: further evidence supporting gene dosage as a mechanism for Charcot-Marie-Tooth disease type 1A. Hum Mutat. 1996;8:362.","journal-title":"Hum Mutat"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"41310","DOI":"10.1074\/jbc.M112.398099","volume":"287","author":"Y Nihei","year":"2012","unstructured":"Nihei Y, Ito D, Suzuki N. Roles of ataxin-2 in pathological cascades mediated by TAR DNA-binding protein 43 (TDP-43) and Fused in Sarcoma (FUS). J Biol Chem. 2012;287:41310\u201323.","journal-title":"J Biol Chem"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"14697","DOI":"10.1021\/bi991470c","volume":"38","author":"HD Kim","year":"1999","unstructured":"Kim HD, Choe J, Seo YS. The sen1(+) gene of Schizosaccharomyces pombe, a homologue of budding yeast SEN1, encodes an RNA and DNA helicase. Biochemistry. 1999;38:14697\u2013710.","journal-title":"Biochemistry"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nature02046","volume":"425","author":"S Ghaemmaghami","year":"2003","unstructured":"Ghaemmaghami S, et al. Global analysis of protein expression in yeast. Nature. 2003;425:737\u201341.","journal-title":"Nature"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"47150","DOI":"10.1074\/jbc.M109581200","volume":"276","author":"T Borggrefe","year":"2001","unstructured":"Borggrefe T, Davis R, Bareket-Samish A, Kornberg RD. Quantitation of the RNA polymerase II transcription machinery in yeast. J Biol Chem. 2001;276:47150\u20133.","journal-title":"J Biol Chem"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1073\/pnas.94.12.6075","volume":"94","author":"JQ Svejstrup","year":"1997","unstructured":"Svejstrup JQ, et al. Evidence for a mediator cycle at the initiation of transcription. Proc Natl Acad Sci U S A. 1997;94:6075\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/msb.2011.82","volume":"7","author":"M Beck","year":"2011","unstructured":"Beck M, et al. The quantitative proteome of a human cell line. Mol Syst Biol. 2011;7:549.","journal-title":"Mol Syst Biol"},{"key":"10_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/17482968.2011.566930","volume":"12","author":"F Avemaria","year":"2011","unstructured":"Avemaria F, et al. Mutation in the senataxin gene found in a patient affected by familial ALS with juvenile onset and slow progression. Amyotroph Lateral Scler. 2011;12:228\u201330.","journal-title":"Amyotroph Lateral Scler"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nmd.2011.09.006","volume":"22","author":"S Rudnik-Schoneborn","year":"2012","unstructured":"Rudnik-Schoneborn S, Arning L, Epplen JT, Zerres K. SETX gene mutation in a family diagnosed autosomal dominant proximal spinal muscular atrophy. Neuromuscul Disord. 2012;22:258\u201362.","journal-title":"Neuromuscul Disord"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1093\/brain\/awp211","volume":"132","author":"M Anheim","year":"2009","unstructured":"Anheim M, et al. Ataxia with oculomotor apraxia type 2: clinical, biological and genotype\/phenotype correlation study of a cohort of 90 patients. Brain. 2009;132:2688\u201398.","journal-title":"Brain"},{"key":"10_CR20","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1083\/jcb.200701042","volume":"177","author":"A Suraweera","year":"2007","unstructured":"Suraweera A, et al. Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J Cell Biol. 2007;177:969\u201379.","journal-title":"J Cell Biol"},{"key":"10_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.braindev.2013.10.003","volume":"36","author":"C Vantaggiato","year":"2014","unstructured":"Vantaggiato C, et al. Novel SETX variants in a patient with ataxia, neuropathy, and oculomotor apraxia are associated with normal sensitivity to oxidative DNA damaging agents. Brain Dev. 2014;36:682\u20139.","journal-title":"Brain Dev"},{"key":"10_CR22","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.dnarep.2010.10.012","volume":"10","author":"A Amicis De","year":"2011","unstructured":"De Amicis A, et al. Role of senataxin in DNA damage and telomeric stability. DNA Repair. 2011;10:199\u2013209.","journal-title":"DNA Repair"},{"key":"10_CR23","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1002\/ajmg.a.31816","volume":"143","author":"DR Lynch","year":"2007","unstructured":"Lynch DR, Braastad CD, Nagan N. Ovarian failure in ataxia with oculomotor apraxia type 2. Am J Med Genet A. 2007;143:1775\u20137.","journal-title":"Am J Med Genet A"},{"key":"10_CR24","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1126\/science.1165942","volume":"323","author":"C Vance","year":"2009","unstructured":"Vance C, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208\u201311.","journal-title":"Science"},{"key":"10_CR25","first-page":"127","volume":"19","author":"CL Bennett","year":"2015","unstructured":"Bennett CL, La Spada AR. Unwinding the role of senataxin in neurodegeneration. Discov Med. 2015;19:127\u201336.","journal-title":"Discov Med"},{"key":"10_CR26","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1128\/MCB.16.10.5477","volume":"16","author":"Y Weng","year":"1996","unstructured":"Weng Y, Czaplinski K, Peltz SW. Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol Cell Biol. 1996;16:5477\u201390.","journal-title":"Mol Cell Biol"},{"key":"10_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/hmg\/10.2.99","volume":"10","author":"SM Medghalchi","year":"2001","unstructured":"Medghalchi SM, et al. Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability. Hum Mol Genet. 2001;10:99\u2013105.","journal-title":"Hum Mol Genet"},{"key":"10_CR28","doi-asserted-by":"publisher","first-page":"7821","DOI":"10.1073\/pnas.1509744112","volume":"112","author":"SJ Barmada","year":"2015","unstructured":"Barmada SJ, et al. Amelioration of toxicity in neuronal models of amyotrophic lateral sclerosis by hUPF1. Proc Natl Acad Sci U S A. 2015;112:7821\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/ng703","volume":"29","author":"K Grohmann","year":"2001","unstructured":"Grohmann K, et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet. 2001;29:75\u20137.","journal-title":"Nat Genet"},{"key":"10_CR30","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/hmg\/7.10.1531","volume":"7","author":"S Lefebvre","year":"1998","unstructured":"Lefebvre S, Burglen L, Frezal J, Munnich A, Melki J. The role of the SMN gene in proximal spinal muscular atrophy. Hum Mol Genet. 1998;7:1531\u20136.","journal-title":"Hum Mol Genet"},{"key":"10_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/S0896-6273(00)80652-2","volume":"21","author":"GA Cox","year":"1998","unstructured":"Cox GA, Mahaffey CL, Frankel WN. Identification of the mouse neuromuscular degeneration gene and mapping of a second site suppressor allele. Neuron. 1998;21:1327\u201337.","journal-title":"Neuron"},{"key":"10_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/BF00418026","volume":"249","author":"D Ursic","year":"1995","unstructured":"Ursic D, DeMarini DJ, Culbertson MR. Inactivation of the yeast Sen1 protein affects the localization of nucleolar proteins. Mol Gen Genet. 1995;249:571\u201384.","journal-title":"Mol Gen Genet"},{"key":"10_CR33","doi-asserted-by":"publisher","first-page":"4778","DOI":"10.1093\/nar\/25.23.4778","volume":"25","author":"D Ursic","year":"1997","unstructured":"Ursic D, Himmel KL, Gurley KA, Webb F, Culbertson MR. The yeast SEN1 gene is required for the processing of diverse RNA classes. Nucleic Acids Res. 1997;25:4778\u201385.","journal-title":"Nucleic Acids Res"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/genetics\/118.4.609","volume":"118","author":"M Winey","year":"1988","unstructured":"Winey M, Culbertson MR. Mutations affecting the tRNA-splicing endonuclease activity of Saccharomyces cerevisiae. Genetics. 1988;118:609\u201317.","journal-title":"Genetics"},{"key":"10_CR35","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1128\/MCB.18.12.6885","volume":"18","author":"TP Rasmussen","year":"1998","unstructured":"Rasmussen TP, Culbertson MR. The putative nucleic acid helicase Sen1p is required for formation and stability of termini and for maximal rates of synthesis and levels of accumulation of small nucleolar RNAs in Saccharomyces cerevisiae. Mol Cell Biol. 1998;18:6885\u201396.","journal-title":"Mol Cell Biol"},{"key":"10_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/35095090","volume":"413","author":"EJ Steinmetz","year":"2001","unstructured":"Steinmetz EJ, Conrad NK, Brow DA, Corden JL. RNA-binding protein Nrd1 directs poly(A)-independent 3\u2032-end formation of RNA polymerase II transcripts. Nature. 2001;413:327\u201331.","journal-title":"Nature"},{"key":"10_CR37","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1128\/MCB.16.12.6993","volume":"16","author":"EJ Steinmetz","year":"1996","unstructured":"Steinmetz EJ, Brow DA. Repression of gene expression by an exogenous sequence element acting in concert with a heterogeneous nuclear ribonucleoprotein-like protein, Nrd1, and the putative helicase Sen1. Mol Cell Biol. 1996;16:6993\u20137003.","journal-title":"Mol Cell Biol"},{"key":"10_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molcel.2009.07.028","volume":"36","author":"AG Rondon","year":"2009","unstructured":"Rondon AG, Mischo HE, Kawauchi J, Proudfoot NJ. Fail-safe transcriptional termination for protein-coding genes in S. cerevisiae. Mol Cell. 2009;36:88\u201398.","journal-title":"Mol Cell"},{"key":"10_CR39","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.molcel.2006.10.023","volume":"24","author":"EJ Steinmetz","year":"2006","unstructured":"Steinmetz EJ, et al. Genome-wide distribution of yeast RNA polymerase II and its control by Sen1 helicase. Mol Cell. 2006;24:735\u201346.","journal-title":"Mol Cell"},{"key":"10_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/brain\/aws310","volume":"136","author":"JJ Reynolds","year":"2013","unstructured":"Reynolds JJ, Stewart GS. A single strand that links multiple neuropathologies in human disease. Brain. 2013;136:14\u201327.","journal-title":"Brain"},{"key":"10_CR41","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.molcel.2011.04.026","volume":"42","author":"K Skourti-Stathaki","year":"2011","unstructured":"Skourti-Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA\/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol Cell. 2011;42:794\u2013805.","journal-title":"Mol Cell"},{"key":"10_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0006193","volume":"4","author":"A Banerjee","year":"2009","unstructured":"Banerjee A, Sammarco MC, Ditch S, Wang J, Grabczyk E. A novel tandem reporter quantifies RNA polymerase II termination in mammalian cells. PLoS One. 2009;4:e6193.","journal-title":"PLoS One"},{"key":"10_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003435","volume":"9","author":"OJ Becherel","year":"2013","unstructured":"Becherel OJ, et al. Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLoS Genet. 2013;9:e1003435.","journal-title":"PLoS Genet"},{"key":"10_CR44","doi-asserted-by":"publisher","first-page":"13084","DOI":"10.1073\/pnas.93.23.13084","volume":"93","author":"A Elson","year":"1996","unstructured":"Elson A, et al. Pleiotropic defects in ataxia-telangiectasia protein-deficient mice. Proc Natl Acad Sci U S A. 1996;93:13084\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090219","volume":"9","author":"AJ Yeo","year":"2014","unstructured":"Yeo AJ, et al. R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias. PLoS One. 2014;9:e90219.","journal-title":"PLoS One"},{"key":"10_CR46","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1093\/nar\/gkw1230","volume":"45","author":"Z Han","year":"2017","unstructured":"Han Z, Libri D, Porrua O. Biochemical characterization of the helicase Sen1 provides new insights into the mechanisms of non-coding transcription termination. Nucleic Acids Res. 2017;45:1355\u201370.","journal-title":"Nucleic Acids Res"},{"key":"10_CR47","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ni919","volume":"4","author":"K Yu","year":"2003","unstructured":"Yu K, Chedin F, Hsieh CL, Wilson TE, Lieber MR. R-loops at immunoglobulin class switch regions in the chromosomes of stimulated B cells. Nat Immunol. 2003;4:442\u201351.","journal-title":"Nat Immunol"},{"key":"10_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078837","volume":"8","author":"CL Bennett","year":"2013","unstructured":"Bennett CL, et al. Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide. PLoS One. 2013;8:e78837.","journal-title":"PLoS One"},{"key":"10_CR49","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1101\/gad.224923.113","volume":"27","author":"P Richard","year":"2013","unstructured":"Richard P, Feng S, Manley JL. A SUMO-dependent interaction between Senataxin and the exosome, disrupted in the neurodegenerative disease AOA2, targets the exosome to sites of transcription-induced DNA damage. Genes Dev. 2013;27:2227\u201332.","journal-title":"Genes Dev"},{"key":"10_CR50","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.1093\/hmg\/ddp278","volume":"18","author":"A Suraweera","year":"2009","unstructured":"Suraweera A, et al. Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum Mol Genet. 2009;18:3384\u201396.","journal-title":"Hum Mol Genet"},{"key":"10_CR51","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1126\/science.8351519","volume":"261","author":"HX Deng","year":"1993","unstructured":"Deng HX, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047\u201351.","journal-title":"Science"},{"key":"10_CR52","doi-asserted-by":"publisher","first-page":"6311","DOI":"10.1128\/MCB.15.11.6311","volume":"15","author":"DJ DeMarini","year":"1995","unstructured":"DeMarini DJ, et al. The yeast SEN3 gene encodes a regulatory subunit of the 26S proteasome complex required for ubiquitin-dependent protein degradation in vivo. Mol Cell Biol. 1995;15:6311\u201321.","journal-title":"Mol Cell Biol"},{"key":"10_CR53","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1128\/MCB.24.14.6241-6252.2004","volume":"24","author":"KL Carroll","year":"2004","unstructured":"Carroll KL, Pradhan DA, Granek JA, Clarke ND, Corden JL. Identification of cis elements directing termination of yeast nonpolyadenylated snoRNA transcripts. Mol Cell Biol. 2004;24:6241\u201352.","journal-title":"Mol Cell Biol"},{"key":"10_CR54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.molcel.2005.11.028","volume":"21","author":"L Vasiljeva","year":"2006","unstructured":"Vasiljeva L, Buratowski S. Nrd1 interacts with the nuclear exosome for 3\u2032 processing of RNA polymerase II transcripts. Mol Cell. 2006;21:239\u201348.","journal-title":"Mol Cell"},{"key":"10_CR55","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrm3098","volume":"12","author":"JN Kuehner","year":"2011","unstructured":"Kuehner JN, Pearson EL, Moore C. Unravelling the means to an end: RNA polymerase II transcription termination. Nat Rev Mol Cell Biol. 2011;12:283\u201394.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10_CR56","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1101\/gad.1792809","volume":"23","author":"P Richard","year":"2009","unstructured":"Richard P, Manley JL. Transcription termination by nuclear RNA polymerases. Genes Dev. 2009;23:1247\u201369.","journal-title":"Genes Dev"},{"key":"10_CR57","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nbd.2006.02.007","volume":"23","author":"YZ Chen","year":"2006","unstructured":"Chen YZ, et al. Senataxin, the yeast Sen1p orthologue: characterization of a unique protein in which recessive mutations cause ataxia and dominant mutations cause motor neuron disease. Neurobiol Dis. 2006;23:97\u2013108.","journal-title":"Neurobiol Dis"},{"key":"10_CR58","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.jocn.2013.11.048","volume":"21","author":"RH Roda","year":"2014","unstructured":"Roda RH, Rinaldi C, Singh R, Schindler AB, Blackstone C. Ataxia with oculomotor apraxia type 2 fibroblasts exhibit increased susceptibility to oxidative DNA damage. J Clin Neurosci. 2014;21:1627\u201331.","journal-title":"J Clin Neurosci"},{"key":"10_CR59","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nsmb.2543","volume":"20","author":"A Helmrich","year":"2013","unstructured":"Helmrich A, Ballarino M, Nudler E, Tora L. Transcription-replication encounters, consequences and genomic instability. Nat Struct Mol Biol. 2013;20:412\u20138.","journal-title":"Nat Struct Mol Biol"},{"key":"10_CR60","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.molcel.2011.10.013","volume":"44","author":"A Helmrich","year":"2011","unstructured":"Helmrich A, Ballarino M, Tora L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol Cell. 2011;44:966\u201377.","journal-title":"Mol Cell"},{"key":"10_CR61","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ncb2201","volume":"13","author":"C Lukas","year":"2011","unstructured":"Lukas C, et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol. 2011;13:243\u201353.","journal-title":"Nat Cell Biol"},{"key":"10_CR62","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1093\/hmg\/ddp134","volume":"18","author":"M Planell-Saguer de","year":"2009","unstructured":"de Planell-Saguer M, Schroeder DG, Rodicio MC, Cox GA, Mourelatos Z. Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Hum Mol Genet. 2009;18:2115\u201326.","journal-title":"Hum Mol Genet"},{"key":"10_CR63","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1093\/hmg\/ddh129","volume":"13","author":"TP Maddatu","year":"2004","unstructured":"Maddatu TP, Garvey SM, Schroeder DG, Hampton TG, Cox GA. Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy. Hum Mol Genet. 2004;13:1105\u201315.","journal-title":"Hum Mol Genet"},{"key":"10_CR64","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature11923","volume":"495","author":"T Hanada","year":"2013","unstructured":"Hanada T, et al. CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature. 2013;495:474\u201380.","journal-title":"Nature"},{"key":"10_CR65","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.cell.2014.02.058","volume":"157","author":"E Karaca","year":"2014","unstructured":"Karaca E, et al. Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell. 2014;157:636\u201350.","journal-title":"Cell"},{"key":"10_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature05096","volume":"443","author":"JW Lee","year":"2006","unstructured":"Lee JW, et al. Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature. 2006;443:50\u20135.","journal-title":"Nature"},{"key":"10_CR67","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1126\/science.1249749","volume":"345","author":"R Ishimura","year":"2014","unstructured":"Ishimura R, et al. RNA function. Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration. Science. 2014;345:455\u20139.","journal-title":"Science"},{"key":"10_CR68","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/ng.2254","volume":"44","author":"J Wan","year":"2012","unstructured":"Wan J, et al. Mutations in the RNA exosome component gene EXOSC3 cause pontocerebellar hypoplasia and spinal motor neuron degeneration. Nat Genet. 2012;44:704\u20138.","journal-title":"Nat Genet"},{"key":"10_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12977-015-0182-4","volume":"12","author":"A Erazo","year":"2015","unstructured":"Erazo A, Goff SP. Nuclear matrix protein Matrin 3 is a regulator of ZAP-mediated retroviral restriction. Retrovirology. 2015;12:57.","journal-title":"Retrovirology"},{"key":"10_CR70","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1093\/hmg\/8.10.1893","volume":"8","author":"PA Frischmeyer","year":"1999","unstructured":"Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet. 1999;8:1893\u2013900.","journal-title":"Hum Mol Genet"},{"key":"10_CR71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.semcdb.2014.04.026","volume":"32","author":"DK Li","year":"2014","unstructured":"Li DK, Tisdale S, Lotti F, Pellizzoni L. SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. Semin Cell Dev Biol. 2014;32:22\u20139.","journal-title":"Semin Cell Dev Biol"},{"key":"10_CR72","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1126\/science.aab0983","volume":"349","author":"JP Ling","year":"2015","unstructured":"Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science. 2015;349:650\u20135.","journal-title":"Science"},{"key":"10_CR73","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1126\/science.aaa3650","volume":"347","author":"ET Cirulli","year":"2015","unstructured":"Cirulli ET, et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347:1436\u201341.","journal-title":"Science"},{"key":"10_CR74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004704","volume":"10","author":"J Couthouis","year":"2014","unstructured":"Couthouis J, Raphael AR, Daneshjou R, Gitler AD. Targeted exon capture and sequencing in sporadic amyotrophic lateral sclerosis. PLoS Genet. 2014;10:e1004704.","journal-title":"PLoS Genet"},{"key":"10_CR75","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1136\/jmedgenet-2013-101795","volume":"50","author":"KP Kenna","year":"2013","unstructured":"Kenna KP, et al. Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing. J Med Genet. 2013;50:776\u201383.","journal-title":"J Med Genet"}],"container-title":["Advances in Neurobiology","RNA Metabolism in Neurodegenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-89689-2_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T22:00:31Z","timestamp":1661464831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-89689-2_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319896885","9783319896892"],"references-count":75,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-89689-2_10","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}